# Viromed Medical partners with TriPart for ViroCAP and PulmoPlas launch in Turkey

Viromed Medical AG signed a distribution partnership with TriPart TITAN GmbH & Co. KG to market its ViroCAP and PulmoPlas cold plasma medical devices in Turkey. The sales launch is planned for Q1 2026, with initial orders of 5,000 ViroCAP and 750 PulmoPlas units.

- Type: Partnership
- Announced: 2025-07-24
- Where: Turkey, Türkiye
- Status: announced
- Products: ViroCAP mobile cold plasma device for skin diseases, PulmoPlas cold plasma device for VAP prevention
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Viromed Medical AG](https://endata.com/companies/83861.md)
- [TriPart TITAN GmbH & Co. KG](https://endata.com/companies/86217.md) (partner)

## Sources

- [boersen-zeitung.de](https://www.boersen-zeitung.de/ticker/viromed-medical-ag-vereinbart-vertriebskooperation-mit-tripart-fuer-die-markteinfuehrung-von-virocap-und-pulmoplas-in-der-tuerkei-2), 2025-07-24: "Mit TriPart haben wir einen starken Partner mit direktem Zugang zu medizinischen Einrichtungen und Entscheidern im türkischen Gesundheitswesen gewonnen."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.